BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26044227)

  • 1. Hematopoietic stem cells: cancer involvement and myeloid leukemia.
    Li XL; Xue Y; Yang YJ; Zhang CX; Wang Y; Duan YY; Meng YN; Fu J
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1829-36. PubMed ID: 26044227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia.
    Rodrigues NP; Tipping AJ; Wang Z; Enver T
    Int J Biochem Cell Biol; 2012 Mar; 44(3):457-60. PubMed ID: 22192845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic leukemia.
    Kikushige Y; Miyamoto T
    Int J Hematol; 2015 Nov; 102(5):528-35. PubMed ID: 25644149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors.
    Cozzio A; Passegué E; Ayton PM; Karsunky H; Cleary ML; Weissman IL
    Genes Dev; 2003 Dec; 17(24):3029-35. PubMed ID: 14701873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.
    Kikushige Y; Miyamoto T
    Int J Hematol; 2014 Oct; 100(4):335-40. PubMed ID: 25100497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
    Jordan CT; Guzman ML
    Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic versus acute myelogenous leukemia: a question of self-renewal.
    Jamieson CH; Weissman IL; Passegué E
    Cancer Cell; 2004 Dec; 6(6):531-3. PubMed ID: 15607956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
    Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
    Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional dysregulation during myeloid transformation in AML.
    Pabst T; Mueller BU
    Oncogene; 2007 Oct; 26(47):6829-37. PubMed ID: 17934489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
    Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
    Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironmental regulation of hematopoietic stem cells and its implications in leukemogenesis.
    Seshadri M; Qu CK
    Curr Opin Hematol; 2016 Jul; 23(4):339-45. PubMed ID: 27071022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
    Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
    Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice.
    Yuan Y; Yu H; Boyer MJ; Song X; Cao S; Shen H; Cheng T
    Cancer Res; 2006 Jan; 66(1):343-51. PubMed ID: 16397248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
    Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
    Testa U; Pelosi E
    Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathways involved in the evolution of leukemic stem cells.
    Zhang PY; Yang YJ; Fu CM; Xiang LL; Wang Q; Li XL
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1356-63. PubMed ID: 25967709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
    Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
    Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.